AVALIDE 300-12.5 MG TABLET

irbesartan and hydrochlorothiazide
$9.7125per EA
High Outlier

Strength

12.5; 300 mg/1; mg/1

NDC

00024585630

Classification

Brand

Dosage Form

TABLET, FILM COATED

Route

ORAL

Last Updated

8/21/2024

Approval Type

New Drug (NDA)

FDA Application

NDA020758

On Market Since

1/1/2013

Pharmacological Classes

Angiotensin 2 Receptor Antagonists
Angiotensin 2 Receptor Blocker
Increased Diuresis
Thiazide Diuretic
Thiazides

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

+33.7%

5Y

+33.7%

All

+114.1%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.